Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary

Int J Gynaecol Obstet. 1999 Aug;66(2):189-90. doi: 10.1016/s0020-7292(99)00071-5.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Female
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Neoplasms, Hormone-Dependent / diagnosis
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / drug therapy*
  • Sertoli-Leydig Cell Tumor / diagnosis
  • Sertoli-Leydig Cell Tumor / drug therapy*

Substances

  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone